Warwick Evidence receives funding from the NIHR HTA Programme and the National Institute for Health and Care Excellence (NICE). To find out more about the nature of our work, please visit this page.
We can present here only a very limited selection of the numerous projects we conduct every year. Unlisted projects include research on tuberculosis, fluorouracil chemotherapy, ventricular assist devices (VADs), and many more.
Publications resulting from NICE / NIHR projects and further research can be found here.
Medical Devices: Hips and Knees
In our first TAR contract we worked on an MTA on Total hip replacement and resurfacing arthroplasty for the treatment of pain or disability resulting from end stage arthritis of the hip (Review of technology appraisal guidance 2 and 44, resulted in guidance TA 304).
This work resulted in a number of publications that can be viewed here and there are still more to come!
We are working on a project relating to Autologous chondrocyte implantation in the knee and
Our first success story followed our work on an MTA on Aspirin.
The results published by Warwick Evidence were discussed all over the world, including Azerbaiijan, Brazil, Croatia, Estonia, France, Germany, Greece, Hungary, India, Italy, Latvia, Lebanon, the Middle East, Pakistan, Peru, Poland, Portugal, Romania, Serbia, Spain, Ukraine, USA, Zimbabwe, Vietnam, and also in a lot of international journals, e.g. Hospi Medica and MTB Europe.
Warwick Evidence has worked on four projects concerning Gastroenterology:
12/48/01 Faecal calprotectin testing for inflammatory and non-inflammatory bowel disease
Warwick Evidence is developing a speciality for MS-related projects:
Members of Warwick Evidence have worked on Diabetes-related projects and will be working on three more in 2018:
17/46/04: Ertugliflozin monotherapy for treating type 2 diabetes [ID1158]
17/46/05: Ertugliflozin (combination therapy with metformin) for treating type 2 diabetes [ID1159 & ID1160]
17/46/10: Liraglutide for treating diabetes type-2 cardiovascular disease [ID1197]
Dapagliflozin in Combination [ID427]